Grants and Contracts Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/19/12 → 12/31/14 |
Funding
- Purdue Pharma LP: $11,420.00
OTR3002 - An Open-Label, Extension Study to Assess the Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-Release Tablets in Opioid Experienced Children Who Completed the OTR3001 Study
- Bayliff, Sherry (PI)